Study types
- article 2
- other 2
- rct 1
Condition tags
- endometriosis 5
Top journals
Frequent coauthors
- B Cherruau 2
- D Borderie 2
- Maxime Dougados 2
- C Pélissier 1
- C Lucas 1
- C Simonetta 1
- E Elefant 1
- B Hédon 1
- F De Ceuninck 1
- B Biour 1
BACKGROUND: It has been proposed that hormonal supplementation during prolonged GnRH agonist therapy prevents hypoestrogenic side effects, including bone loss. The optimal combination for long-term treatments with safe metabolic profile rem…
To evaluate bone biochemical markers as predictors of the efficacy of a hormone replacement therapy (HRT), we studied the bone changes induced by the cessation and return of ovarian function in 28 patients treated for 6 months with a GnRH a…
This prospective longitudinal study was undertaken to examine the short-term effects (6 months) of estrogen withdrawal on the circulating IGF system. A series of 40 patients suffering from endometriosis was studied before and after a 6-mont…
OBJECTIVE: To evaluate the teratogenic or fetal risk of a long-acting GnRH agonist (GnRH-a) triptoreline acetate (Decapeptyl; Ipsen-Biotech, Inc., Paris, France), inadvertently administrated in the first weeks of pregnancy. DESIGN: Prospec…